Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cipher Pharmaceuticals Inc (CPH.TO)

Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cipher Pharmaceuticals Inc 5750 Explorer Drive Suite 404 Mississauga ON L4W 0A9 CAN

https://www.cipherpharma.com P: 905-602-5840 F: 905-602-0628

Sector:

Medical

Description:

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Key Statistics

Overview:

Market Capitalization, $K 379,784
Shares Outstanding, K 25,394
Annual Sales, $ 33,363 K
Annual Net Income, $ 11,545 K
Last Quarter Sales, $ 12,833 K
Last Quarter Net Income, $ 5,501 K
60-Month Beta 0.85
% of Institutional Shareholders 3.24%

Growth:

1-Year Return 5.52%
3-Year Return 288.83%
5-Year Return 1,157.98%
5-Year Revenue Growth 8.24%
5-Year Earnings Growth 30.83%

Per-Share Information:

Most Recent Earnings 0.21 on 11/06/25
Next Earnings Date N/A
Earnings Per Share ttm 0.67
EPS Growth vs. Prev Qtr -4.55%
EPS Growth vs. Prev Year 4.76%
Dividend Payout Ratio 0.00%

CPH.TO Ratios

Ratio
Price/Earnings ttm 16.34
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 16.32%
Return-on-Assets % 11.52%
Profit Margin % 34.60%
Debt/Equity 0.39
Price/Sales 5.71
Price/Book 2.44
Book Value/Share 6.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar